CRISPR-Cas9 based gene editing of the immune checkpoint NKG2A enhances NK cell mediated cytotoxicity against multiple myeloma

Natural Killer (NK) cells are known for their high intrinsic cytotoxic capacity, and the possibility to be applied as ‘off-the-shelf’ product makes them highly attractive for cell-based immunotherapies. In patients with multiple myeloma (MM), an elevated number of NK cells has been correlated with h...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Tobias Bexte, Jamal Alzubi, Lisa Marie Reindl, Philipp Wendel, Ralf Schubert, Emilia Salzmann-Manrique, Ivana von Metzler, Toni Cathomen, Evelyn Ullrich
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Taylor & Francis Group 2022-12-01
Edice:	OncoImmunology
Témata:	Genome editing CRISPR-Cas NK cells inhibitory receptors immunotherapy NKG2A
On-line přístup:	https://www.tandfonline.com/doi/10.1080/2162402X.2022.2081415
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!